Bausch Health Companies Inc.

Products

Category

Product

Brand

Description

Global Pharmaceutical Drugs Industry (PHM263B)

Salix		It offers GI products, including Xifaxan for the treatment of IBS-D, Glumetza (metformin hydrochloride) for the treatment of type 2 diabetes mellitus, Relistor (methylnaltrexone) used to treat severe chronic pain, Trulance (plecanatide) and Plenvu.
Diversified Products		Its segment offers pharmaceutical products in neurology, generic products and other therapeutic classes. The pharmaceuticals products subsegment offers Wellbutrin XL for the treatment of major depressive disorder, Cuprimine for the treatment of Wilson’s disease, Migranal (dihydroergotamine mesylate) nasal spray to treat an active migraine headache and many others. The generic product subsegment offers Diastat (diazepam rectal gel) for rectal administration for certain patients with epilepsy and Uceris AG (budesonide) for the treatment of ulcerative colitis.
Bausch + Lomb (Eye Health & Vision Care)		Prescription drugs: Vyzulta (glaucoma), Lotemax (eye inflammation) Contact lenses: ULTRA, Biotrue, PureVision. Eye drops & solutions: Lumify (redness relief), Artelac (dry eye treatment)

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment